Asparaginase (Escherichia coli)
Indication
It is suitable for the treatment of acute lymphocytic leukemia (ALL), acute granulocytic leukemia, acute monocytic leukemia, chronic lymphocytic leukemia, Hodgkin's disease and non-Hodgkin's lymphoma, melanoma, etc. This product has an inhibitory effect on the proliferation of the above-mentioned tumor cells, and has the best effect on the induction remission of acute lymphoblastic leukemia in children. Sometimes it may also be effective for patients who relapse after remission with some commonly used chemotherapy drugs, but the remission period is short when used alone, and it is easy to produce drug resistance, so it is often used in combination with other chemotherapy drugs to improve the efficacy.
Manufacturer
Changzhou Qianhong Biopharma Co., Ltd.
-
Founded in:
2003-04-30 -
Address:
No. 518, Yunhe Road, Xinbei District, Changzhou -
Tax NO.:
91320400748726864T -
Registered Funds:
1,279.8 million yuan -
Website:
-
Email: